Remove Ablation Remove Cardiomyopathy Remove Tachycardia
article thumbnail

Ventricular tachycardia ablation with pentaspline pulsed field technology in two patients with ischemic cardiomyopathy

Journal of Cardiovascular Electrophysiology

Abstract Introduction Due to its unique features, pulsed field ablation (PFA) could potentially overcome some limitations of current radiofrequency (RF) ventricular tachycardia (VT) ablation. Methods Two patients with ischemic cardiomyopathy and previously failed RF VT ablations were treated with PFA.

article thumbnail

Efficacy of Catheter Ablation for Ventricular Tachycardia in Ischemic Cardiomyopathy Patients without an ICD Implantation

HeartRhythm

Implantable cardioverter defibrillator (ICD) prevents sudden cardiac death (SCD) in patients with ischemic cardiomyopathy (ICM). Catheter ablation has been shown to effectively reduce ventricular tachycardia (VT) recurrence, yet its efficacy in patients without an ICD implantation remains uncertain.

article thumbnail

PO-01-149 DIFFERENCES IN THE OUTCOMES OF CATHETER ABLATION FOR VENTRICULAR TACHYCARDIA IN NON-ISCHEMIC VERSUS ISCHEMIC CARDIOMYOPATHY

HeartRhythm

Catheter ablation is an effective tool to reduce ventricular tachycardia (VT) burden. There is a lack of robust data studying the intraprocedural characteristics and outcomes of VT ablation in patients with non-ischemic (NICM) versus ischemic cardiomyopathy (ICM).

article thumbnail

PO-01-119 LONG-TERM OUTCOMES OF VENTRICULAR TACHYCARDIA ABLATION IN PATIENTS WITH ISCHEMIC AND NON-ISCHEMIC CARDIOMYOPATHY: A PROPENSITY-SCORE MATCHED ANALYSIS

HeartRhythm

Catheter ablation (CA) is effective in the treatment of ventricular tachycardia (VT). Although some data suggest patients with non-ischemic cardiomyopathy (NCIM) have worse outcomes compared to those with an ischemic etiology (ICM), direct comparisons are scarcely reported.

article thumbnail

Ablation of Ventricular Tachycardia in Patients with ischemic cardiomyopathy and without an ICD – For the times they are a-changin´?

HeartRhythm

Recent advancements in catheter ablation for structural ventricular tachycardia (VT), such as high-density mapping and cardiac imaging-based detection of target areas, have significantly improved the efficacy of ablation procedures.

article thumbnail

PO-06-054 VENTRICULAR TACHYCARDIA IN ISCHEMIC VS NON-ISCHEMIC CARDIOMYOPATHY- TRENDS OF MORTALITY, CATHETER ABLATIONS, RESOURCE UTILIZATION, AND READMISSIONS

HeartRhythm

Ventricular Tachycardia (VT) is an important cause of morbidity and mortality in structural heart Disease. Current literature is limited in direct comparison of VT in ischemic (ICM) compared to non-ischemic cardiomyopathy (NICM).

article thumbnail

PO-05-044 FLUOROLESS CATHETER ABLATION OF AN ATRIAL TACHYCARDIA ORIGINATING FROM THE DISTAL LEFT ATRIAL APPENDAGE IN A PREGNANT WOMAN WITH TACHYCARDIA-INDUCED CARDIOMYOPATHY

HeartRhythm

Supraventricular tachycardias are the most common arrhythmias that occur during pregnancy. When pharmacologic therapy fails, fluoroless catheter ablation utilizing electroanatomic mapping systems and intracardiac echocardiography (ICE) may be considered. Pharmacologic therapy is often preferred in pregnant patients.